BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811-820. [PMID: 19269519 DOI: 10.1016/s0140-6736(09)60484-0] [Cited by in Crossref: 969] [Cited by in F6Publishing: 317] [Article Influence: 80.8] [Reference Citation Analysis]
Number Citing Articles
1 Rödel C. Radiotherapy: Preoperative chemoradiotherapy for rectal cancer. Nat Rev Clin Oncol. 2010;7:129-130. [PMID: 20190793 DOI: 10.1038/nrclinonc.2010.10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
2 Guckenberger M, Saur G, Wehner D, Sweeney RA, Thalheimer A, Germer CT, Flentje M. Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Strahlenther Onkol 2012;188:551-7. [PMID: 22638934 DOI: 10.1007/s00066-012-0131-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
3 Mokarram P, Albokashy M, Zarghooni M, Moosavi MA, Sepehri Z, Chen QM, Hudecki A, Sargazi A, Alizadeh J, Moghadam AR, Hashemi M, Movassagh H, Klonisch T, Owji AA, Łos MJ, Ghavami S. New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets. Autophagy 2017;13:781-819. [PMID: 28358273 DOI: 10.1080/15548627.2017.1290751] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 18.8] [Reference Citation Analysis]
4 Shogan BD, Carlisle EM, Alverdy JC, Umanskiy K. Do We Really Know Why Colorectal Anastomoses Leak? J Gastrointest Surg 2013;17:1698-707. [DOI: 10.1007/s11605-013-2227-0] [Cited by in Crossref: 124] [Cited by in F6Publishing: 106] [Article Influence: 15.5] [Reference Citation Analysis]
5 Baek JY, Yu JI, Park HC, Choi DH, Yoo GS, Cho WK, Lee WY, Yun SH, Cho YB, Park YA, Kim HC. Risk factors for locoregional recurrence in patients with pathologic T3N0 rectal cancer with negative resection margin treated by surgery alone. Radiat Oncol J 2019;37:110-6. [PMID: 31266292 DOI: 10.3857/roj.2019.00199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Ide S, Okugawa Y, Omura Y, Yamamoto A, Ichikawa T, Kitajima T, Shimura T, Imaoka H, Fujikawa H, Yasuda H, Yokoe T, Okita Y, Ohi M, Toiyama Y. Geriatric nutritional risk index predicts cancer prognosis in patients with local advanced rectal cancer undergoing chemoradiotherapy followed by curative surgery. World J Surg Oncol 2021;19:34. [PMID: 33516219 DOI: 10.1186/s12957-021-02139-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Hayano K, Fujishiro T, Sahani DV, Satoh A, Aoyagi T, Ohira G, Tochigi T, Matsubara H, Shuto K. Computed tomography perfusion imaging as a potential imaging biomarker of colorectal cancer. World J Gastroenterol 2014; 20(46): 17345-17351 [PMID: 25516645 DOI: 10.3748/wjg.v20.i46.17345] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
8 Feeney G, Sehgal R, Sheehan M, Hogan A, Regan M, Joyce M, Kerin M. Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol 2019; 25(33): 4850-4869 [PMID: 31543678 DOI: 10.3748/wjg.v25.i33.4850] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 31] [Article Influence: 22.5] [Reference Citation Analysis]
9 Park YY, Lee KY, Kim NK, Lee SB, Kim GR, Min BS, Oh ST. Impact of Adjuvant Chemotherapy Completion on Oncologic Outcomes in ypTNMstage 2 Rectal Cancer Patients. Ann Coloproctol 2019;35:335-41. [PMID: 31937073 DOI: 10.3393/ac.2019.03.10] [Reference Citation Analysis]
10 Kim CH, Lee SY, Kim HR, Kim YJ. Nomogram Prediction of Anastomotic Leakage and Determination of an Effective Surgical Strategy for Reducing Anastomotic Leakage after Laparoscopic Rectal Cancer Surgery. Gastroenterol Res Pract 2017;2017:4510561. [PMID: 28592967 DOI: 10.1155/2017/4510561] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
11 Riesco-Martinez MC, Fernandez-Martos C, Gravalos-Castro C, Espinosa-Olarte P, La Salvia A, Robles-Diaz L, Modrego-Sanchez A, Garcia-Carbonero R. Impact of Total Neoadjuvant Therapy vs. Standard Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis of Randomized Trials. Cancers (Basel) 2020;12:E3655. [PMID: 33291454 DOI: 10.3390/cancers12123655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Bökkerink GMJ, van der Wilt GJ, de Jong D, van Krieken HHJM, Bleichrodt RP, de Wilt JHW, Bremers AJA. Value of macrobiopsies and transanal endoscopic microsurgery in the histological work-up of rectal neoplasms: A retrospective study. World J Gastrointest Oncol 2017; 9(6): 251-256 [PMID: 28656075 DOI: 10.4251/wjgo.v9.i6.251] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Morris EJ, Finan PJ, Spencer K, Geh I, Crellin A, Quirke P, Thomas JD, Lawton S, Adams R, Sebag-Montefiore D. Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service. Clin Oncol (R Coll Radiol) 2016;28:522-31. [PMID: 26936609 DOI: 10.1016/j.clon.2016.02.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
14 Song JH, Jeong JU, Lee JH, Kim SH, Cho HM, Um JW, Jang HS; Korean Clinical Practice Guideline for Colon and Rectal Cancer Committee. Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials. Radiat Oncol J 2017;35:198-207. [PMID: 29037017 DOI: 10.3857/roj.2017.00059] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
15 Yuan C, Xu XH, Wang XL, Xu L, Chen Z, Li YQ. Relationship between serum uric acid and metastatic and nonmetastatic rectal cancer patients with undergoing no chemotherapy. Medicine (Baltimore) 2016;95:e5463. [PMID: 27893692 DOI: 10.1097/MD.0000000000005463] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
16 On J, Aly EH. 'Watch and wait' in rectal cancer: summary of the current evidence. Int J Colorectal Dis 2018;33:1159-68. [PMID: 29978363 DOI: 10.1007/s00384-018-3116-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
17 Tomizawa K, Miura Y, Fukui Y, Hanaoka Y, Toda S, Moriyama J, Inoshita N, Ozaki Y, Takano T, Matoba S, Kuroyanagi H. Curative resection for locally advanced sigmoid colon cancer using neoadjuvant chemotherapy with FOLFOX plus panitumumab: A case report. Int J Surg Case Rep 2017;31:128-31. [PMID: 28135678 DOI: 10.1016/j.ijscr.2017.01.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Glimelius B. Neo-adjuvant radiotherapy in rectal cancer. World J Gastroenterol 2013; 19(46): 8489-8501 [PMID: 24379566 DOI: 10.3748/wjg.v19.i46.8489] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
19 Marquardt C, Kalev G, Schiedeck T. Intraoperative fluorescence angiography with indocyanine green: retrospective evaluation and detailed analysis of our single-center 5-year experience focused on colorectal surgery. Innov Surg Sci 2020;5:35-42. [PMID: 33506092 DOI: 10.1515/iss-2020-0009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Guadagni S, Fiorentini G, Clementi M, Palumbo P, Mambrini A, Masedu F. Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques. Updates Surg 2017;69:403-10. [PMID: 28791628 DOI: 10.1007/s13304-017-0480-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
21 Wang YW, Huang LY, Song CL, Zhuo CH, Shi DB, Cai GX, Xu Y, Cai SJ, Li XX. Laparoscopic vs open abdominoperineal resection in the multimodality management of low rectal cancers. World J Gastroenterol 2015; 21(35): 10174-10183 [PMID: 26401082 DOI: 10.3748/wjg.v21.i35.10174] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
22 KSAR Study Group for Rectal Cancer. Essential Items for Structured Reporting of Rectal Cancer MRI: 2016 Consensus Recommendation from the Korean Society of Abdominal Radiology. Korean J Radiol 2017;18:132-51. [PMID: 28096724 DOI: 10.3348/kjr.2017.18.1.132] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
23 Ciria JP, Eguiguren M, Cafiero S, Uranga I, Diaz de Cerio I, Querejeta A, Urraca JM, Minguez J, Guimon E, Puertolas JR. Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma? Rep Pract Oncol Radiother 2015;20:1-11. [PMID: 25535578 DOI: 10.1016/j.rpor.2014.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
24 Jin F, Luo H, Zhou J, Wu Y, Sun H, Liu H, Zheng X, Wang Y. Dose-time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer. Ther Adv Med Oncol 2020;12:1758835920907537. [PMID: 32165928 DOI: 10.1177/1758835920907537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
25 Yu M, Jang HS, Jeon DM, Cheon GS, Lee HC, Chung MJ, Kim SH, Lee JH. Dosimetric evaluation of Tomotherapy and four-box field conformal radiotherapy in locally advanced rectal cancer. Radiat Oncol J 2013;31:252-9. [PMID: 24501715 DOI: 10.3857/roj.2013.31.4.252] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
26 Saklani AP, Lim DR, Hur H, Min BS, Baik SH, Lee KY, Kim NK. Robotic versus laparoscopic surgery for mid-low rectal cancer after neoadjuvant chemoradiation therapy: comparison of oncologic outcomes. Int J Colorectal Dis. 2013;28:1689-1698. [PMID: 23948968 DOI: 10.1007/s00384-013-1756-z] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
27 Margalit O, Mamtani R, Lawrence YR, Yang YX, Baruch EN, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B. Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent? Mol Clin Oncol 2019;10:555-9. [PMID: 30967950 DOI: 10.3892/mco.2019.1825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Jeong DH, Lee HB, Hur H, Min BS, Baik SH, Kim NK. Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer. J Korean Surg Soc 2013;84:338-45. [PMID: 23741691 DOI: 10.4174/jkss.2013.84.6.338] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
29 Yoo RN, Kim HJ. Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy. Ann Gastroenterol Surg. 2019;3:356-367. [PMID: 31346574 DOI: 10.1002/ags3.12253] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
30 Corner C, Khimji F, Tsang Y, Harrison M, Glynne-Jones R, Hughes R. Comparison of conventional and three-dimensional conformal CT planning techniques for preoperative chemoradiotherapy for locally advanced rectal cancer. Br J Radiol 2011;84:173-8. [PMID: 21257837 DOI: 10.1259/bjr/33089685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
31 Cai G, Zhu J, Hu W, Zhang Z. Accelerated hyperfractionated intensity-modulated radiotherapy for recurrent/unresectable rectal cancer in patients with previous pelvic irradiation: results of a phase II study. Radiat Oncol 2014;9:278. [PMID: 25497847 DOI: 10.1186/s13014-014-0278-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
32 Gillespie MA, Steele CW, Lannagan TRM, Sansom OJ, Roxburgh CSD. Pre-clinical modelling of rectal cancer to develop novel radiotherapy-based treatment strategies. Oncol Rev 2021;15:511. [PMID: 34249240 DOI: 10.4081/oncol.2021.511] [Reference Citation Analysis]
33 Fu XL, Fang Z, Shu LH, Tao GQ, Wang JQ, Rui ZL, Zhang YJ, Tian ZQ. Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer. Oncotarget 2017;8:34340-51. [PMID: 28423720 DOI: 10.18632/oncotarget.16127] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
34 Marijnen CAM, Peters FP, Rödel C, Bujko K, Haustermans K, Fokas E, Glynne-Jones R, Valentini V, Spindler KG, Guren MG, Maingon P, Calvo FA, Pares O, Glimelius B, Sebag-Montefiore D. International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic. Radiother Oncol 2020;148:213-5. [PMID: 32342861 DOI: 10.1016/j.radonc.2020.03.039] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 36.0] [Reference Citation Analysis]
35 Jacobi N, Gieseler F. [Diagnosis and treatment of rectal cancer]. Med Klin (Munich) 2010;105:730-6. [PMID: 20981593 DOI: 10.1007/s00063-010-1125-7] [Reference Citation Analysis]
36 Siegel R, Cuesta MA, Targarona E, Bader FG, Morino M, Corcelles R, Lacy AM, Påhlman L, Haglind E, Bujko K, Bruch HP, Heiss MM, Eikermann M, Neugebauer EA; European Association for Endoscopic Surgery (EAES). Laparoscopic extraperitoneal rectal cancer surgery: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2011;25:2423-40. [PMID: 21701921 DOI: 10.1007/s00464-011-1805-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
37 Xynos E, Tekkis P, Gouvas N, Vini L, Chrysou E, Tzardi M, Vassiliou V, Boukovinas I, Agalianos C, Androulakis N, Athanasiadis A, Christodoulou C, Dervenis C, Emmanouilidis C, Georgiou P, Katopodi O, Kountourakis P, Makatsoris T, Papakostas P, Papamichael D, Pechlivanides G, Pentheroudakis G, Pilpilidis I, Sgouros J, Triantopoulou C, Xynogalos S, Karachaliou N, Ziras N, Zoras O, Souglakos J; [the Executive Team on behalf of the Hellenic Society of Medical Oncologists (HeSMO)]. Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol 2016;29:103-26. [PMID: 27064746 DOI: 10.20524/aog.2016.0003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
38 Koelzer VH, Lugli A, Dawson H, Hädrich M, Berger MD, Borner M, Mallaev M, Galván JA, Amsler J, Schnüriger B, Zlobec I, Inderbitzin D. CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival. J Transl Med 2014;12:81. [PMID: 24679169 DOI: 10.1186/1479-5876-12-81] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
39 Chadi SA, Berho M, Wexner SD. Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature. Langenbecks Arch Surg 2015;400:661-73. [PMID: 26250144 DOI: 10.1007/s00423-015-1328-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Roodbeen SX, Blok RD, Borstlap WA, Bemelman WA, Hompes R, Tanis PJ; Dutch Snapshot Research Group. Does oncological outcome differ between restorative and nonrestorative low anterior resection in patients with primary rectal cancer? Colorectal Dis 2021;23:843-52. [PMID: 33245846 DOI: 10.1111/codi.15464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Empuku S, Nakajima K, Akagi T, Kaneko K, Hijiya N, Etoh T, Shiraishi N, Moriyama M, Inomata M. An 80-gene set to predict response to preoperative chemoradiotherapy for rectal cancer by principle component analysis. Mol Clin Oncol 2016;4:733-9. [PMID: 27123272 DOI: 10.3892/mco.2016.806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
42 Bosch SL, Nagtegaal ID. The Importance of the Pathologist’s Role in Assessment of the Quality of the Mesorectum. Curr Colorectal Cancer Rep. 2012;8:90-98. [PMID: 22611342 DOI: 10.1007/s11888-012-0124-7124] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Jung F, Guidolin K, Lee MH, Lam-Tin-Cheung K, Zhao G, Doshi S, Chesney T, Englesakis M, Lukovic J, O'Kane G, Quereshy FA, Chadi SA. Interventions and Outcomes for Neoadjuvant Treatment of T4 Colon Cancer: A Scoping Review. Curr Oncol 2021;28:2065-78. [PMID: 34072615 DOI: 10.3390/curroncol28030191] [Reference Citation Analysis]
44 Treder M, Vogelsang RP, Janssen S, Schild SE, Holländer NH, Rades D. Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal Cancer. In Vivo 2018;32:1481-4. [PMID: 30348705 DOI: 10.21873/invivo.11403] [Reference Citation Analysis]
45 Glynne-Jones R, Chau I. Neoadjuvant therapy before surgical treatment. EJC Suppl 2013;11:45-59. [PMID: 26217113 DOI: 10.1016/j.ejcsup.2013.07.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
46 Lee JL, Lim SB, Yu CS, Park IJ, Yoon YS, Kim CW, Park SH, Lee JS, Hong YS, Kim SY, Kim JE, Kim JH, Park JH, Kim J, Han M. Local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy; a proposed trial. BMC Cancer 2019;19:404. [PMID: 31035949 DOI: 10.1186/s12885-019-5581-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 White R, Foroudi F, Sia J, Marr MA, Lim Joon D. Reduced dose to small bowel with the prone position and a belly board versus the supine position in neoadjuvant 3D conformal radiotherapy for rectal adenocarcinoma. J Med Radiat Sci 2017;64:120-4. [PMID: 27741381 DOI: 10.1002/jmrs.187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
48 Cho SH, Lee IK, Lee YS, Kim MK. The usefulness of transanal tube for reducing anastomotic leak in mid rectal cancer: compared to diverting stoma. Ann Surg Treat Res 2021;100:100-8. [PMID: 33585354 DOI: 10.4174/astr.2021.100.2.100] [Reference Citation Analysis]
49 Fan WH, Wang FL, Lu ZH, Pan ZZ, Li LR, Gao YH, Chen G, Wu XJ, Ding PR, Zeng ZF, Wan DS. Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial.Chin J Cancer. 2015;34:394-403. [PMID: 26111932 DOI: 10.1186/s40880-015-0024-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
50 Wang QX, Li SH, Zhang X, Xie L, Cai PQ, An X, Pan ZZ, Ding PR. Identification of locally advanced rectal cancer with low risk of local recurrence. PLoS One 2015;10:e0117141. [PMID: 25629521 DOI: 10.1371/journal.pone.0117141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
51 Fan XJ, Wan XB, Huang Y, Cai HM, Fu XH, Yang ZL, Chen DK, Song SX, Wu PH, Liu Q, Wang L, Wang JP. Epithelial-mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer. Br J Cancer 2012;106:1735-41. [PMID: 22538975 DOI: 10.1038/bjc.2012.82] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
52 Glimelius B. Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future. Ups J Med Sci 2012;117:225-36. [PMID: 22512246 DOI: 10.3109/03009734.2012.658974] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
53 Stintzing S. Management of colorectal cancer. F1000Prime Rep 2014;6:108. [PMID: 25580262 DOI: 10.12703/P6-108] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
54 Moslim MA, Bastawrous AL, Jeyarajah DR. Neoadjuvant Pelvic Radiotherapy in the Management of Rectal Cancer with Synchronous Liver Metastases: Is It Worth It? J Gastrointest Surg 2021. [PMID: 34100244 DOI: 10.1007/s11605-021-05042-w] [Reference Citation Analysis]
55 Zhou Z, Nimeiri HS, Benson AB 3rd. Preoperative chemotherapy for locally advanced resectable colon cancer - a new treatment paradigm in colon cancer? Ann Transl Med 2013;1:11. [PMID: 25332956 DOI: 10.3978/j.issn.2305-5839.2013.01.01] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
56 Lai S, Lou X, Fan X, Sun W, Deng Y, Wang J, Huang Y, Dou R. Density and distribution of lymphocytes in pretherapeutic rectal cancer and response to neoadjuvant therapy. Gastroenterol Rep (Oxf) 2020;8:445-52. [PMID: 33442477 DOI: 10.1093/gastro/goaa016] [Reference Citation Analysis]
57 Zhai Z, Wang Z, Jin M, Zhang K. Peripheral blood CD45RO+T cells is a predictor of the effectiveness of neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Medicine (Baltimore) 2021;100:e26214. [PMID: 34160385 DOI: 10.1097/MD.0000000000026214] [Reference Citation Analysis]
58 Romesser PB, Wu AJ, Cercek A, Smith JJ, Weiser M, Saltz L, Garcia-Aguilar J, Crane CH. Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center. Adv Radiat Oncol. 2020;. [PMID: 32322758 DOI: 10.1016/j.adro.2020.04.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
59 Guckenberger M, Wulf J, Thalheimer A, Wehner D, Thiede A, Müller G, Sailer M, Flentje M. Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results. Radiat Oncol 2009;4:67. [PMID: 20025752 DOI: 10.1186/1748-717X-4-67] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
60 Peng Y, Wang L, Du C, Gu J. Expression of vascular endothelial growth factor can predict distant metastasis and disease-free survival for clinical stage III rectal cancer following 30-Gy/10-f preoperative radiotherapy. Int J Colorectal Dis. 2012;27:1555-1560. [PMID: 22645074 DOI: 10.1007/s00384-012-1485-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
61 Lin WC, Wang WH, Lin YH, Leu JD, Cheng SY, Chen YJ, Hwang JJ. Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinoma‑bearing mouse model. Oncol Rep 2018;40:1390-400. [PMID: 30015952 DOI: 10.3892/or.2018.6568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Osti MF, Agolli L, Bracci S, Masoni L, Valeriani M, Falco T, De Sanctis V, Maurizi Enrici R. Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients. Int J Colorectal Dis. 2014;29:835-842. [PMID: 24825722 DOI: 10.1007/s00384-014-1879-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
63 Bellows CF, Jaffe B, Bacigalupo L, Pucciarelli S, Gagliardi G. Clinical significance of magnetic resonance imaging findings in rectal cancer. World J Radiol 2011; 3(4): 92-104 [PMID: 21532870 DOI: 10.4329/wjr.v3.i4.92] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
64 van den Berg I, van de Weerd S, Roodhart JML, Vink GR, van den Braak RRJC, Jimenez CR, Elias SG, van Vliet D, Koelink M, Hong E, van Grevenstein WMU, van Oijen MGH, Beets-Tan RGH, van Krieken JHJM, IJzermans JNM, Medema JP, Koopman M; CONNECTION-study group. Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study. BMC Cancer 2020;20:776. [PMID: 32811457 DOI: 10.1186/s12885-020-07236-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Spatola C, Privitera G, Milazzotto R, Tocco A, Acquaviva G, Marletta F, Marino L, Di Grazia A, Salvo R, Cartia G, Platania A, Molino L, Santacaterina A, Mattace Raso M, Frosina P, Ianni R, Bono M, Liardo L, Bonanno S, La Paglia L, Federico M, Fazio I, Mortellaro G, Ferrera G, Tripoli A, Evangelista G, Daidone A, Biti G, Badalamenti M, Ognibene L, Cacciola A, Parisi S, Pergolizzi S. Trends in combined radio-chemotherapy for locally advanced rectal cancer: a survey among radiation oncology centers of Sicily region on behalf of AIRO. Radiol Med 2019;124:671-81. [PMID: 30806918 DOI: 10.1007/s11547-019-01007-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
66 Veerankutty FH, Nair N, Chacko S, Sreekumar VI, Varma D, Kurumboor P. Oncological adequacy of laparoscopic rectal cancer resection: An audit in Indian perspective. J Minim Access Surg 2020;16:251-5. [PMID: 31793449 DOI: 10.4103/jmas.JMAS_272_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Contin P, Kulu Y, Bruckner T, Sturm M, Welsch T, Müller-stich BP, Huber J, Büchler MW, Ulrich A. Comparative analysis of late functional outcome following preoperative radiation therapy or chemoradiotherapy and surgery or surgery alone in rectal cancer. Int J Colorectal Dis 2014;29:165-75. [DOI: 10.1007/s00384-013-1780-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
68 Pach R, Kulig J, Richter P, Gach T, Szura M, Kowalska T. Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up. Langenbecks Arch Surg. 2012;397:801-807. [PMID: 22170083 DOI: 10.1007/s00423-011-0890-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
69 Trakarnsanga A, Gönen M, Shia J, Nash GM, Temple LK, Guillem JG, Paty PB, Goodman KA, Wu A, Gollub M. Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. J Natl Cancer Inst. 2014;106:pii: dju248. [PMID: 25249540 DOI: 10.1093/jnci/dju248] [Cited by in Crossref: 100] [Cited by in F6Publishing: 96] [Article Influence: 14.3] [Reference Citation Analysis]
70 Qiaoli W, Yongping H, Wei X, Guoqiang X, Yunhe J, Qiuyan L, Cheng L, Mengling G, Jiayi L, Wei X, Yi Y. Preoperative short-course radiotherapy (5 × 5 Gy) with delayed surgery versus preoperative long-course radiotherapy for locally resectable rectal cancer: a meta-analysis. Int J Colorectal Dis 2019;34:2171-83. [PMID: 31745621 DOI: 10.1007/s00384-019-03433-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
71 São Julião GP, Celentano JP, Alexandre FA, Vailati BB. Local Excision and Endoscopic Resections for Early Rectal Cancer. Clin Colon Rectal Surg 2017;30:313-23. [PMID: 29184466 DOI: 10.1055/s-0037-1606108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Kawada K, Sakai Y. Preoperative, intraoperative and postoperative risk factors for anastomotic leakage after laparoscopic low anterior resection with double stapling technique anastomosis. World J Gastroenterol 2016; 22(25): 5718-5727 [PMID: 27433085 DOI: 10.3748/wjg.v22.i25.5718] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
73 Song C, Song S, Kim JS, Oh HK, Kim DW, Lee KW, Kim JH, Eom KY, Kim IA, Kang SB. Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis. PLoS One 2015;10:e0123657. [PMID: 25902069 DOI: 10.1371/journal.pone.0123657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
74 Li S, Gong Y, Yang Y, Guo Q, Qian J, Tian Y. Evaluation of small bowel motion and feasibility of using the peritoneal space to replace bowel loops for dose constraints during intensity-modulated radiotherapy for rectal cancer. Radiat Oncol 2020;15:211. [PMID: 32873308 DOI: 10.1186/s13014-020-01650-z] [Reference Citation Analysis]
75 Uehara K, Nagino M. Neoadjuvant treatment for locally advanced rectal cancer: a systematic review. Surg Today 2016;46:161-8. [PMID: 26170102 DOI: 10.1007/s00595-015-1218-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
76 Enríquez-Navascués JM, Borda N, Lizerazu A, Placer C, Elosegui JL, Ciria JP, Lacasta A, Bujanda L. Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol 2011; 17(13): 1674-1684 [PMID: 21483626 DOI: 10.3748/wjg.v17.i13.1674] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
77 Tural D, Selcukbiricik F, Yıldız Ö, Elcin O, Erdamar S, Güney S, Demireli F, Büyükünal E, Serdengeçti S. Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer. Int J Clin Oncol 2014;19:889-96. [PMID: 24218281 DOI: 10.1007/s10147-013-0636-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
78 Morino M, Risio M, Bach S, Beets-tan R, Bujko K, Panis Y, Quirke P, Rembacken B, Rullier E, Saito Y, Young-fadok T, Allaix ME. Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc 2015;29:755-73. [DOI: 10.1007/s00464-015-4067-3] [Cited by in Crossref: 75] [Cited by in F6Publishing: 54] [Article Influence: 12.5] [Reference Citation Analysis]
79 Zheng H, Guo T, Wu Y, Li C, Cai S, Liu F, Xu Y. Rectovaginal fistula after low anterior resection in Chinese patients with colorectal cancer. Oncotarget. 2017;8:73123-73132. [PMID: 29069855 DOI: 10.18632/oncotarget.17046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
80 Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, Barni S. Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials. J Gastrointest Oncol 2017;8:39-48. [PMID: 28280607 DOI: 10.21037/jgo.2016.11.03] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
81 He F, Yu L, Ding Y, Li ZH, Wang J, Zheng J, Chen HY, Liu S, Pang XL, Ajani JA, Wan XB. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer.Cancer Sci. 2020;111:4205-4217. [PMID: 32860448 DOI: 10.1111/cas.14636] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
82 Cheng YK, Qin QY, Huang XY, Lan P, Wang L, Gao X, Ma TH. Effect of interval between preoperative radiotherapy and surgery on clinical outcome and radiation proctitis in rectal cancer from FOWARC trial. Cancer Med 2020;9:912-9. [PMID: 31828956 DOI: 10.1002/cam4.2755] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Yang Y, Gu X, Li Z, Zheng C, Wang Z, Zhou M, Chen Z, Li M, Li D, Xiang J. Whole-exome sequencing of rectal cancer identifies locally recurrent mutations in the Wnt pathway. Aging (Albany NY) 2021;13:23262-83. [PMID: 34642262 DOI: 10.18632/aging.203618] [Reference Citation Analysis]
84 Marks JH, Montenegro GA, Salem JF, Shields MV, Marks GJ. Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer. Tech Coloproctol. 2016;20:467-473. [PMID: 27178183 DOI: 10.1007/s10151-016-1482-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 8.2] [Reference Citation Analysis]
85 Rectal Cancer Alliance Of Canada (RCAC)., Rectal Cancer Alliance Of Canada RCAC. QuickSilver: A Phase II Study Using Magnetic Resonance Imaging Criteria to Identify "Good Prognosis" Rectal Cancer Patients Eligible for Primary Surgery. JMIR Res Protoc 2015;4:e41. [PMID: 25871328 DOI: 10.2196/resprot.4151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
86 Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O'Callaghan C, Myint AS, Bessell E, Thompson LC, Parmar M, Stephens RJ, Sebag-Montefiore D; MRC CR07/NCIC-CTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821-828. [PMID: 19269520 DOI: 10.1016/s0140-6736(09)60485-2] [Cited by in Crossref: 651] [Cited by in F6Publishing: 198] [Article Influence: 54.3] [Reference Citation Analysis]
87 Chen TY, Emmertsen KJ, Laurberg S. What Are the Best Questionnaires To Capture Anorectal Function After Surgery in Rectal Cancer? Curr Colorectal Cancer Rep 2015;11:37-43. [PMID: 25663833 DOI: 10.1007/s11888-014-0217-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
88 Wang L, Zhai ZW, Ji DB, Li ZW, Gu J. Prognostic value of CD45RO(+) tumor-infiltrating lymphocytes for locally advanced rectal cancer following 30 Gy/10f neoadjuvant radiotherapy. Int J Colorectal Dis 2015;30:753-60. [PMID: 25935450 DOI: 10.1007/s00384-015-2226-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
89 Wong JSM, Tan GHC, Chia CS, Ong CAJ, Teo MCC. Management of synchronous lateral pelvic nodal metastasis in rectal cancer in the era of neoadjuvant chemoradiation: A systemic review. World J Gastrointest Surg 2020; 12(5): 247-258 [PMID: 32551030 DOI: 10.4240/wjgs.v12.i5.247] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
90 Cao Y, Zhang G, Bao H, Ren J, Wang Z, Zhang J, Zhao Z, Yan X, Chai Y, Zhou J. Development of a dual-energy spectral computed tomography-based nomogram for the preoperative discrimination of histological grade in colorectal adenocarcinoma patients. J Gastrointest Oncol 2021;12:544-55. [PMID: 34012648 DOI: 10.21037/jgo-20-368] [Reference Citation Analysis]
91 Guan X, Wei R, Yang R, Lu Z, Liu E, Zhao Z, Chen H, Yang M, Liu Z, Jiang Z, Wang X. Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms. JAMA Netw Open 2021;4:e2031661. [PMID: 33416884 DOI: 10.1001/jamanetworkopen.2020.31661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Wang L, Gu GL, Li ZW, Peng YF, Gu J. Abdominoperineal excision following preoperative radiotherapy for rectal cancer: Unfavorable prognosis even with negative circumferential resection margin. World J Gastroenterol 2014; 20(27): 9138-9145 [PMID: 25083087 DOI: 10.3748/wjg.v20.i27.9138] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
93 Mahvi DA, Liu R, Grinstaff MW, Colson YL, Raut CP. Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies. CA Cancer J Clin. 2018;68:488-505. [PMID: 30328620 DOI: 10.3322/caac.21498] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 23.0] [Reference Citation Analysis]
94 Mirnezami AH, Sagar PM. Surgery for recurrent rectal cancer: technical notes and management of complications. Tech Coloproctol. 2010;14:209-216. [PMID: 20461538 DOI: 10.1007/s10151-010-0585-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
95 王君辅, 张平峰, 谢勇, 胡林, 李昌荣, 李红浪. 合理应用肠腔灌洗液对直肠癌手术预后复发影响的研究进展. 世界华人消化杂志 2015; 23(22): 3576-3581 [DOI: 10.11569/wcjd.v23.i22.3576] [Reference Citation Analysis]
96 Sammour T, Chang GJ. Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: Mutually exclusive or mutually beneficial? Ann Gastroenterol Surg 2018;2:348-50. [PMID: 30238075 DOI: 10.1002/ags3.12197] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
97 Roeder F, Meldolesi E, Gerum S, Valentini V, Rödel C. Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review. Radiat Oncol 2020;15:262. [PMID: 33172475 DOI: 10.1186/s13014-020-01695-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
98 Pach R, Richter P, Sierzega M, Papp N, Szczepanik A. Preoperative Short-Course Radiotherapy and Surgery versus Surgery Alone for Patients with Rectal Cancer: A Propensity Score-Matched Analysis at 18-Year Follow-Up. Biomedicines 2021;9:725. [PMID: 34202691 DOI: 10.3390/biomedicines9070725] [Reference Citation Analysis]
99 Simunovic M, Coates A, Goldsmith CH, Thabane L, Reeson D, Smith A, McLeod RS, DeNardi F, Whelan TJ, Levine MN. The cluster-randomized Quality Initiative in Rectal Cancer trial: evaluating a quality-improvement strategy in surgery. CMAJ 2010;182:1301-6. [PMID: 20696797 DOI: 10.1503/cmaj.091883] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
100 Yoon HI, Chung Y, Chang JS, Lee JY, Park SJ, Koom WS. Evaluating Variations of Bladder Volume Using an Ultrasound Scanner in Rectal Cancer Patients during Chemoradiation: Is Protocol-Based Full Bladder Maintenance Using a Bladder Scanner Useful to Maintain the Bladder Volume? PLoS One. 2015;10:e0128791. [PMID: 26039198 DOI: 10.1371/journal.pone.0128791] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
101 Lu NN, Jin J, Wang SL, Wang WH, Song YW, Liu YP, Ren H, Fang H, Liu XF, Yu ZH, Li YX. Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer. PLoS One 2015;10:e0124601. [PMID: 25915948 DOI: 10.1371/journal.pone.0124601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
102 Kennedy ED, Simunovic M, Jhaveri K, Kirsch R, Brierley J, Drolet S, Brown C, Vos PM, Xiong W, MacLean T, Kanthan S, Stotland P, Raphael S, Chow G, O'Brien CA, Cho C, Streutker C, Wong R, Schmocker S, Liberman S, Reinhold C, Kopek N, Marcus V, Bouchard A, Lavoie C, Morin S, Périgny M, Wright A, Neumann K, Clarke S, Patil NG, Arnason T, Williams L, McLeod R, Brown G, Mathieson A, Pooni A, Baxter NN. Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical Trial. JAMA Oncol 2019;5:961-6. [PMID: 30973610 DOI: 10.1001/jamaoncol.2019.0186] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 27.0] [Reference Citation Analysis]
103 Kalyan A, Rozelle S, Benson A 3rd. Neoadjuvant treatment of rectal cancer: where are we now? Gastroenterol Rep (Oxf). 2016;4:206-209. [PMID: 27412436 DOI: 10.1093/gastro/gow017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
104 Vonk DT, Hazard LJ. Do all locally advanced rectal cancers require radiation? A review of literature in the modern era. J Gastrointest Oncol. 2010;1:45-54. [PMID: 22811804 DOI: 10.3978/j.issn.2078-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Shi C, Zhou H, Li X, Cai Y. A Retrospective Analysis on Two-week Short-course Pre-operative Radiotherapy in Elderly Patients with Resectable Locally Advanced Rectal Cancer. Sci Rep 2016;6:37866. [PMID: 27886277 DOI: 10.1038/srep37866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
106 Freischlag K, Sun Z, Adam MA, Kim J, Palta M, Czito BG, Migaly J, Mantyh CR. Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer. JAMA Surg 2017;152:558-64. [PMID: 28273303 DOI: 10.1001/jamasurg.2017.0010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
107 Wu SG, Zhang WW, Sun JY, He ZY, Su GQ, Li FY. Preoperative radiotherapy improves survival in rectal signet-ring cell carcinoma-a population-based study. Radiat Oncol 2017;12:141. [PMID: 28835256 DOI: 10.1186/s13014-017-0874-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
108 Gaertner WB, Kwaan MR, Madoff RD, Melton GB. Rectal cancer: An evidence-based update for primary care providers. World J Gastroenterol 2015; 21(25): 7659-7671 [PMID: 26167068 DOI: 10.3748/wjg.v21.i25.7659] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
109 Huang WS, Kuan FC, Lin MH, Chen MF, Chen WC. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer. Ann Surg Oncol 2020;27:4309-18. [PMID: 32794029 DOI: 10.1245/s10434-020-09018-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Kornmann M, Staib L, Wiegel T, Kreuser ED, Kron M, Baumann W, Henne-Bruns D, Link KH. Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α. Br J Cancer 2010;103:1163-72. [PMID: 20877353 DOI: 10.1038/sj.bjc.6605871] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
111 Shiraishi T, Sasaki T, Ikeda K, Tsukada Y, Nishizawa Y, Ito M. Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer. BMC Cancer 2019;19:1222. [PMID: 31842797 DOI: 10.1186/s12885-019-6424-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
112 Guan X, Jiang Z, Ma T, Liu Z, Hu H, Zhao Z, Song D, Chen Y, Wang G, Wang X. Radiotherapy dose led to a substantial prolongation of survival in patients with locally advanced rectosigmoid junction cancer: a large population based study. Oncotarget 2016;7:28408-19. [PMID: 27070089 DOI: 10.18632/oncotarget.8630] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
113 Böyük A, Aday U, Gültürk B, Bozdağ A, Aksu A, Kutluer N. Effect of splenic flexure mobilization performed via medial-to-lateral and superior-to-inferior approach on early clinical outcomes in elective laparoscopic resection of rectal cancer. Wideochir Inne Tech Maloinwazyjne 2019;14:509-15. [PMID: 31908696 DOI: 10.5114/wiitm.2019.85224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Zhang RX, Zhou ZG, Lu SX, Lu ZH, Wan DS, Pan ZZ, Wu XJ, Chen G. Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients. Sci Rep 2017;7:16043. [PMID: 29167471 DOI: 10.1038/s41598-017-16153-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
115 Lim JW, Chew MH, Lim KH, Tang CL. Close distal margins do not increase rectal cancer recurrence after sphincter-saving surgery without neoadjuvant therapy. Int J Colorectal Dis. 2012;27:1285-1294. [PMID: 22918660 DOI: 10.1007/s00384-012-1467-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
116 Park JS, Sakai Y, Simon NSM, Law WL, Kim HR, Oh JH, Shan HCY, Kwak SG, Choi GS. Long-Term Survival and Local Relapse Following Surgery Without Radiotherapy for Locally Advanced Upper Rectal Cancer: An International Multi-Institutional Study. Medicine (Baltimore) 2016;95:e2990. [PMID: 27258487 DOI: 10.1097/MD.0000000000002990] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
117 Sun Y, Chi P, Lin H, Lu X, Huang Y, Xu Z, Huang S, Wang X. A nomogram predicting pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: implications for organ preservation strategies. Oncotarget 2017;8:67732-43. [PMID: 28978067 DOI: 10.18632/oncotarget.18821] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
118 Rahal R, Forte T, Lockwood G, Klein-Geltink J, Bryant H. Recently published indicators allow for comparison of radiation treatment rates relative to evidence-based guidelines for rectal cancer. Curr Oncol 2012;19:175-6. [PMID: 22670097 DOI: 10.3747/co.19.1065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
119 Park IJ, Yu CS. Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapy. World J Gastroenterol 2014; 20(8): 2023-2029 [PMID: 24587677 DOI: 10.3748/wjg.v20.i8.2023] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
120 Song L, Yin J. Application of Texture Analysis Based on Sagittal Fat-Suppression and Oblique Axial T2-Weighted Magnetic Resonance Imaging to Identify Lymph Node Invasion Status of Rectal Cancer. Front Oncol 2020;10:1364. [PMID: 32850437 DOI: 10.3389/fonc.2020.01364] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
121 Sautter-Bihl ML, Hohenberger W, Fietkau R, Rödel C, Schmidberger H, Sauer R. Rectal cancer : when is the local recurrence risk low enough to refrain from the aim to prevent it? Strahlenther Onkol 2013;189:105-10. [PMID: 23299826 DOI: 10.1007/s00066-012-0299-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
122 Simpson GS, Eardley N, McNicol F, Healey P, Hughes M, Rooney PS. Circumferential resection margin (CRM) positivity after MRI assessment and adjuvant treatment in 189 patients undergoing rectal cancer resection. Int J Colorectal Dis. 2014;29:585-590. [PMID: 24651956 DOI: 10.1007/s00384-014-1846-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
123 Alongi F, Fersino S, Mazzola R, Fiorentino A, Giaj-Levra N, Ricchetti F, Ruggieri R, Di Paola G, Cirillo M, Gori S, Salgarello M, Zamboni G, Ruffo G. Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer. Clin Transl Oncol 2017;19:189-96. [PMID: 27271749 DOI: 10.1007/s12094-016-1522-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
124 Kim MB, Hong TS, Wo JY. Treatment of stage II-III rectal cancer patients. Curr Oncol Rep 2014;16:362. [PMID: 24323626 DOI: 10.1007/s11912-013-0362-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
125 Park EJ, Kang J, Hur H, Min BS, Baik SH, Lee KY, Kim NK. Different clinical features according to the anastomotic leakage subtypes after rectal cancer surgeries: contained vs. free leakages.PLoS One. 2018;13:e0208572. [PMID: 30540826 DOI: 10.1371/journal.pone.0208572] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Lordick F, Gockel I. Chances, risks and limitations of neoadjuvant therapy in surgical oncology. Innov Surg Sci 2016;1:3-11. [PMID: 31579713 DOI: 10.1515/iss-2016-0004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
127 Peng J, Ding Y, Tu S, Shi D, Sun L, Li X, Wu H, Cai S. Prognostic nomograms for predicting survival and distant metastases in locally advanced rectal cancers. PLoS One 2014;9:e106344. [PMID: 25171093 DOI: 10.1371/journal.pone.0106344] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
128 Oh SJ, Shin JY. Risk factors of circumferential resection margin involvement in the patients with extraperitoneal rectal cancer. J Korean Surg Soc 2012;82:165-71. [PMID: 22403750 DOI: 10.4174/jkss.2012.82.3.165] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
129 Huang L, Li TJ, Zhang JW, Liu S, Fu BS, Liu W. Neoadjuvant chemotherapy followed by surgery versus surgery alone for colorectal cancer: meta-analysis of randomized controlled trials. Medicine (Baltimore) 2014;93:e231. [PMID: 25526442 DOI: 10.1097/MD.0000000000000231] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
130 Rengo M, Picchia S, Marzi S, Bellini D, Caruso D, Caterino M, Ciolina M, De Santis D, Musio D, Tombolini V, Laghi A. Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. Oncotarget 2017;8:114746-55. [PMID: 29383117 DOI: 10.18632/oncotarget.21778] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
131 Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 2020;5:567-72. [PMID: 32775771 DOI: 10.1016/j.adro.2020.04.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
132 McGee SF, AlGhareeb W, Ahmad CH, Armstrong D, Babak S, Berry S, Biagi J, Booth C, Bossé D, Champion P, Colwell B, Finn N, Goel R, Gray S, Green J, Harb M, Hyde A, Jeyakumar A, Jonker D, Kanagaratnam S, Kavan P, MacMillan A, Muinuddin A, Patil N, Porter G, Powell E, Ramjeesingh R, Raza M, Rorke S, Seal M, Servidio-Italiano F, Siddiqui J, Simms J, Smithson L, Snow S, St-Hilaire E, Stuckless T, Tate A, Tehfe M, Thirlwell M, Tsvetkova E, Valdes M, Vickers M, Virik K, Welch S, Marginean C, Asmis T. Eastern Canadian Colorectal Cancer Consensus Conference 2017. Curr Oncol 2018;25:262-74. [PMID: 30111967 DOI: 10.3747/co.25.4083] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
133 Selby P, Kaplan R, Cameron D, Cooper M, Seymour M. The Royal College of Physicians Simms Lecture, 6 December 2011: clinical research networks and the benefits of intensive healthcare systems. Clin Med (Lond) 2012;12:446-52. [PMID: 23101146 DOI: 10.7861/clinmedicine.12-5-446] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
134 Hugen N, Brown G, Glynne-Jones R, de Wilt JH, Nagtegaal ID. Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol 2016;13:361-9. [PMID: 26323388 DOI: 10.1038/nrclinonc.2015.140] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 14.7] [Reference Citation Analysis]
135 Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727 [PMID: 25320509 DOI: 10.3748/wjg.v20.i38.13718] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
136 Simunovic M, Grubac V, Zbuk K, Wong R, Coates A. Role of the status of the mesorectal fascia in the selection of patients with rectal cancer for preoperative radiation therapy: a retrospective cohort study. Can J Surg 2018;61:332-8. [PMID: 30247008 DOI: 10.1503/cjs.009417] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Benard A, Zeestraten EC, Goossens-Beumer IJ, Putter H, van de Velde CJ, Hoon DS, Kuppen PJ. DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence. Apoptosis 2014;19:1581-93. [PMID: 25064172 DOI: 10.1007/s10495-014-1022-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
138 Lee JH, Chie EK, Jeong SY, Kim TY, Kim DY, Kim TH, Kim SY, Baek JY, Chang HJ, Kim MJ, Park SC, Oh JH, Kim SH, Lee JH, Choi DH, Park HC, Kang SB, Kim JS. Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer: A Multicenter Validation Study. Cancer Res Treat 2018;50:506-17. [PMID: 28546522 DOI: 10.4143/crt.2016.607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
139 Thompson MK, Poortmans P, Chalmers AJ, Faivre-Finn C, Hall E, Huddart RA, Lievens Y, Sebag-Montefiore D, Coles CE. Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? Br J Cancer 2018;119:389-407. [PMID: 30061587 DOI: 10.1038/s41416-018-0201-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 16.3] [Reference Citation Analysis]
140 Touloumtzidis A, Sostmann B, Hilgers N, Renter MA, Kühn P, Goretzki PE, Lammers BJ. Functional long-term results after rectal cancer surgery--technique of the athermal mesorectal excision. Int J Colorectal Dis 2014;29:285-92. [PMID: 24306821 DOI: 10.1007/s00384-013-1805-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 van Gijn W, van de Velde CJ. 2010 SSO John Wayne clinical research lecture: rectal cancer outcome improvements in Europe: population-based outcome registrations will conquer the world. Ann Surg Oncol. 2011;18:691-696. [PMID: 20844966 DOI: 10.1245/s10434-010-1326-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
142 Dapper H, Oechsner M, Münch S, Borm K, Peeken J, Mayinger M, Combs SE, Habermehl D. Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer. Radiat Oncol 2018;13:169. [PMID: 30189877 DOI: 10.1186/s13014-018-1120-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
143 Baral J, Schön MR, Ruppert R, Ptok H, Strassburg J, Brosi P, Kreis ME, Lewin A, Sauer J, Sawicki S, Schiffmann L, Winde G, Junginger T, Merkel S, Hermanek P. [Spincter preservation after selective chemoradiotherapy of rectal cancer. Interim results of the OCUM study]. Chirurg 2015;86:1138-44. [PMID: 26347011 DOI: 10.1007/s00104-015-0083-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
144 Levick BA, Gilbert AJ, Spencer KL, Downing A, Taylor JC, Finan PJ, Sebag-Montefiore DJ, Morris EJA. Time to Surgery Following Short-Course Radiotherapy in Rectal Cancer and its Impact on Postoperative Outcomes. A Population-Based Study Across the English National Health Service, 2009-2014. Clin Oncol (R Coll Radiol) 2020;32:e46-52. [PMID: 31477416 DOI: 10.1016/j.clon.2019.08.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
145 Barcellini A, Vitolo V, Cobianchi L, Peloso A, Vanoli A, Mirandola A, Facoetti A, Fiore MR, Iannalfi A, Vischioni B, Cuccia F, Ronchi S, Bonora M, Riva G, Petrucci R, D'Ippolito E, Mas FD, Preda L, Valvo F. Re-irradiation With Carbon Ion Radiotherapy for Pelvic Rectal Cancer Recurrences in Patients Previously Irradiated to the Pelvis. In Vivo 2020;34:1547-53. [PMID: 32354961 DOI: 10.21873/invivo.11944] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
146 Ahmed S, Johnson K, Ahmed O, Iqbal N. Advances in the management of colorectal cancer: from biology to treatment. Int J Colorectal Dis 2014;29:1031-42. [PMID: 24953060 DOI: 10.1007/s00384-014-1928-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 6.3] [Reference Citation Analysis]
147 Nardone V, Reginelli A, Scala F, Carbone SF, Mazzei MA, Sebaste L, Carfagno T, Battaglia G, Pastina P, Correale P, Tini P, Pellino G, Cappabianca S, Pirtoli L. Magnetic-Resonance-Imaging Texture Analysis Predicts Early Progression in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiation. Gastroenterol Res Pract 2019;2019:8505798. [PMID: 30847005 DOI: 10.1155/2019/8505798] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
148 Zhao Q, Li Y, Wang J, Zhang J, Qiao X, Tan B, Tian Y, Shi G, Xu Q, Li R, Liu Y, Yang P. Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction. Am J Med Sci 2015;349:472-6. [PMID: 25996101 DOI: 10.1097/MAJ.0000000000000476] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
149 Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, Barni S. Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials. J Gastrointest Oncol 2017;8:39-48. [PMID: 28280607 DOI: 10.21037/jgo.2016.11.03] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
150 Yang J, Xu H, Guo X, Zhang J, Ye X, Yang Y, Ma X. Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy. Sci Rep 2018;8:3044. [PMID: 29445100 DOI: 10.1038/s41598-018-21093-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
151 Song SH, Park JS, Kang MK, Choi GS, Park SY, Kim HJ, Kim JG, Kang BW, Baek JH, Baek DW, Kim JC, Park SH, Cho SH, Seo AN. Initial experience of preoperative short-course radiotherapy followed by oxaliplatin-based consolidation chemotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2021;36:1279-86. [PMID: 33547945 DOI: 10.1007/s00384-021-03875-0] [Reference Citation Analysis]
152 Hong TS, Mamon H. Short-course versus standard chemoradiation in T3 rectal cancer. Oncologist 2011;16:717-21. [PMID: 21586661 DOI: 10.1634/theoncologist.2011-0052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
153 Audisio RA, Papamichael D. Treatment of colorectal cancer in older patients. Nat Rev Gastroenterol Hepatol. 2012;9:716-725. [PMID: 23045000 DOI: 10.1038/nrgastro.2012.196] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
154 Räsänen M, Renkonen-Sinisalo L, Mustonen H, Lepistö A. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study. World J Surg Oncol 2019;17:139. [PMID: 31395058 DOI: 10.1186/s12957-019-1670-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
155 Zaanan A, Park JM, Tougeron D, Huang S, Wu TT, Foster NR, Sinicrope FA. Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma. Int J Cancer. 2015;137:1498-1502. [PMID: 25708267 DOI: 10.1002/ijc.29496] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
156 Du CZ, Xue WC, Cai Y, Li M, Gu J. Lymphovascular invasion in rectal cancer following neoadjuvant radiotherapy: A retrospective cohort study. World J Gastroenterol 2009; 15(30): 3793-3798 [PMID: 19673022 DOI: 10.3748/wjg.15.3793] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
157 Glimelius B. On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery. Ups J Med Sci 2017;122:1-10. [PMID: 28256956 DOI: 10.1080/03009734.2016.1274806] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
158 Rigter LS, Rijkmans EC, Inderson A, van den Ende RPJ, Kerkhof EM, Ketelaars M, van Dieren J, Veenendaal RA, van Triest B, Marijnen CAM, van der Heide UA, van Leerdam ME. EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types. Endosc Int Open 2019;7:E1357-64. [PMID: 31673605 DOI: 10.1055/a-0958-2148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
159 Boland PM, Fakih M. The emerging role of neoadjuvant chemotherapy for rectal cancer. J Gastrointest Oncol. 2014;5:362-373. [PMID: 25276409 DOI: 10.3978/j.issn.2078-6891.2014.060] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
160 Burke JR, Brown P, Quyn A, Lambie H, Tolan D, Sagar P. Tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study. BJS Open 2020. [PMID: 32996713 DOI: 10.1002/bjs5.50355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
161 Goldenberg BA, Holliday EB, Helewa RM, Singh H. Rectal Cancer in 2018: A Primer for the Gastroenterologist. Am J Gastroenterol. 2018;. [PMID: 30008472 DOI: 10.1038/s41395-018-0180-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
162 Häfner MF, Debus J. Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives. Visc Med 2016;32:172-7. [PMID: 27493944 DOI: 10.1159/000446486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
163 Ortega CD, Perez RO. Role of magnetic resonance imaging in organ-preserving strategies for the management of patients with rectal cancer. Insights Imaging 2019;10:59. [PMID: 31147789 DOI: 10.1186/s13244-019-0742-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Combs SE, Kieser M, Habermehl D, Weitz J, Jäger D, Fossati P, Orrechia R, Engenhart-Cabillic R, Pötter R, Dosanjh M, Jäkel O, Büchler MW, Debus J. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial. BMC Cancer 2012;12:137. [PMID: 22472035 DOI: 10.1186/1471-2407-12-137] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
165 Shin SJ, Yoon HI, Kim NK, Lee KY, Min BS, Ahn JB, Keum KC, Koom WS. Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases. Radiat Oncol 2011;6:99. [PMID: 21864368 DOI: 10.1186/1748-717X-6-99] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
166 Sinukumar S, Patil P, Engineer R, Desouza A, Saklani A. Clinical outcome of patients with complete pathological response to neoadjuvant chemoradiotherapy for locally advanced rectal cancers: the Indian scenario. Gastroenterol Res Pract 2014;2014:867841. [PMID: 25610460 DOI: 10.1155/2014/867841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
167 Rickles AS, Dietz DW, Chang GJ, Wexner SD, Berho ME, Remzi FH, Greene FL, Fleshman JW, Abbas MA, Peters W, Noyes K, Monson JR, Fleming FJ; Consortium for Optimizing the Treatment of Rectal Cancer (OSTRiCh). High Rate of Positive Circumferential Resection Margins Following Rectal Cancer Surgery: A Call to Action. Ann Surg. 2015;262:891-898. [PMID: 26473651 DOI: 10.1097/sla.0000000000001391] [Cited by in Crossref: 85] [Cited by in F6Publishing: 35] [Article Influence: 17.0] [Reference Citation Analysis]
168 Body A, Prenen H, Latham S, Lam M, Tipping-Smith S, Raghunath A, Segelov E. The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer. Cancer Manag Res 2021;13:2567-79. [PMID: 33762848 DOI: 10.2147/CMAR.S262870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
169 Papaccio F, Roselló S, Huerta M, Gambardella V, Tarazona N, Fleitas T, Roda D, Cervantes A. Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Cancers (Basel) 2020;12:E3611. [PMID: 33287114 DOI: 10.3390/cancers12123611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
170 Kreis ME, Ruppert R, Ptok H, Strassburg J, Brosi P, Lewin A, Schön MR, Sauer J, Junginger T, Merkel S, Hermanek P; OCUM study group. Use of Preoperative Magnetic Resonance Imaging to Select Patients with Rectal Cancer for Neoadjuvant Chemoradiation--Interim Analysis of the German OCUM Trial (NCT01325649). J Gastrointest Surg 2016;20:25-32; discussion 32-3. [PMID: 26556476 DOI: 10.1007/s11605-015-3011-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
171 Shapiro R, Ahmed Ali U, Lavery IC, Kiran RP. Endorectal ultrasound does not reliably identify patients with uT3 rectal cancer who can avoid neoadjuvant chemoradiotherapy. Int J Colorectal Dis 2013;28:993-1000. [PMID: 23377857 DOI: 10.1007/s00384-013-1645-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
172 Currie A, Burns EM, Aylin P, Darzi A, Faiz OD, Ziprin P; Imperial College Healthcare NHS trust Colorectal Cancer MDT. The impact of shortened postgraduate surgical training on colorectal cancer outcome. Int J Colorectal Dis 2014;29:631-8. [PMID: 24599298 DOI: 10.1007/s00384-014-1843-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
173 Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol 2017;8:990-7. [PMID: 29299359 DOI: 10.21037/jgo.2017.09.02] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
174 Arezzo A, Bianco F, Agresta F, Coco C, Faletti R, Krivocapic Z, Rotondano G, Santoro GA, Vettoretto N, De Franciscis S, Belli A, Romano GM; Italian Society of Colorectal Surgery. Practice parameters for early rectal cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines. Tech Coloproctol 2015;19:587-93. [PMID: 26408174 DOI: 10.1007/s10151-015-1362-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
175 Glynne-Jones R, Hava N, Goh V, Bosompem S, Bridgewater J, Chau I, Gaya A, Wasan H, Moran B, Melcher L, MacDonald A, Osborne M, Beare S, Jitlal M, Lopes A, Hall M, West N, Quirke P, Wong WL, Harrison M;  Bacchus investigators. Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum. BMC Cancer. 2015;15:764. [PMID: 26493588 DOI: 10.1186/s12885-015-1764-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
176 Zaghloul H, Abbas A, Abdulah D. Tumor Microenvironment Mediators CD8+- and FOXP3+-Labeled T Lymphocytes Are Prospective Prognosticators in Curatively Treated Rectal Cancer Patients. J Gastrointest Cancer 2021;52:177-86. [PMID: 32112202 DOI: 10.1007/s12029-020-00376-1] [Reference Citation Analysis]
177 Sorrentino L, Guaglio M, Battaglia L, Bonfanti G, Vitellaro M, Bianchi AC, Milione M, Belli F. Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study. Int J Colorectal Dis 2019;34:2161-9. [PMID: 31741026 DOI: 10.1007/s00384-019-03446-4] [Reference Citation Analysis]
178 Liu F, Tong T, Huang D, Yuan W, Li D, Lin J, Cai S, Xu Y, Chen W, Sun Y, Zhuang J. CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial. BMJ Open 2019;9:e017637. [PMID: 30700474 DOI: 10.1136/bmjopen-2017-017637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
179 Hu F, Tang W, Sun Y, Wan D, Cai S, Zhang Z, Grimm R, Yan X, Fu C, Tong T. The value of diffusion kurtosis imaging in assessing pathological complete response to neoadjuvant chemoradiation therapy in rectal cancer: a comparison with conventional diffusion-weighted imaging. Oncotarget. 2017;8:75597-75606. [PMID: 29088894 DOI: 10.18632/oncotarget.17491] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
180 Huh JW, Lee WY, Kim SH, Park YA, Cho YB, Yun SH, Kim HC, Park HC, Choi DH, Park JO, Park YS, Chun HK. Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis. Yonsei Med J 2015;56:82-8. [PMID: 25510750 DOI: 10.3349/ymj.2015.56.1.82] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
181 Park SH, Kim JC. Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules. Radiat Oncol J 2016;34:96-105. [PMID: 27306773 DOI: 10.3857/roj.2016.01704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
182 Díaz Beveridge R, Aparicio J, Tormo A, Estevan R, Artes J, Giménez A, Segura Á, Roldán S, Palasí R, Ramos D. Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience. Clin Transl Oncol 2012;14:471-80. [PMID: 22634537 DOI: 10.1007/s12094-012-0826-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
183 García-Albéniz X, Gallego R, Hofheinz RD, Fernández-Esparrach G, Ayuso-Colella JR, Bombí JA, Conill C, Cuatrecasas M, Delgado S, Ginés A, Miquel R, Pagés M, Pineda E, Pereira V, Sosa A, Reig O, Victoria I, Feliz L, María de Lacy A, Castells A, Burkholder I, Hochhaus A, Maurel J. Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation. World J Gastroenterol 2014; 20(42): 15820-15829 [PMID: 25400468 DOI: 10.3748/wjg.v20.i42.15820] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
184 Kim JH. Controversial issues in radiotherapy for rectal cancer: a systematic review. Radiat Oncol J 2017;35:295-305. [PMID: 29325395 DOI: 10.3857/roj.2017.00395] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
185 Chen J, Zhang Z, Chang W, Yi T, Feng Q, Zhu D, He G, Wei Y. Short-Term and Long-Term Outcomes in Mid and Low Rectal Cancer With Robotic Surgery. Front Oncol 2021;11:603073. [PMID: 33767981 DOI: 10.3389/fonc.2021.603073] [Reference Citation Analysis]
186 Katz MHG, Wang H, Balachandran A, Bhosale P, Crane CH, Wang X, Pisters PWT, Lee JE, Vauthey J, Abdalla EK, Wolff R, Abbruzzese J, Varadhachary G, Chopin-laly X, Charnsangavej C, Fleming JB. Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer. J Gastrointest Surg 2012;16:68-79. [DOI: 10.1007/s11605-011-1748-7] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 7.9] [Reference Citation Analysis]
187 Jones WE 3rd, Thomas CR Jr, Herman JM, Abdel-Wahab M, Azad N, Blackstock W, Das P, Goodman KA, Hong TS, Jabbour SK, Konski AA, Koong AC, Rodriguez-Bigas M, Small W Jr, Zook J, Suh WW. ACR appropriateness criteria®  resectable rectal cancer. Radiat Oncol 2012;7:161. [PMID: 23006527 DOI: 10.1186/1748-717X-7-161] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
188 Li ZH, Xie PY, Zhang DF, Li YJ, Wu L, Dong J, Xiao J, Liu ZY. Nomogram for predicting disease-free survival among a multicenter cohort of Chinese patients with locally advanced rectal cancer. Cancer Manag Res 2019;11:2471-83. [PMID: 31114319 DOI: 10.2147/CMAR.S196614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
189 Ahmed S, Bathe O, Berry S, Buie D, Davies J, Doll C, Dowden S, Gill S, Gordon V, Hebbard P, Jones E, Kennecke H, Koski S, Krahn M, Le D, Lim H, Lund C, Luo Y, Mcffadden A, Mcghie J, Mulder K, Park J, Rashidi F, Sami A, Tan KT, Wong R. Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014. Curr Oncol 2015;22:e113-23. [PMID: 25908916 DOI: 10.3747/co.22.2362] [Reference Citation Analysis]
190 Vignali A, Nardi PD. Multidisciplinary treatment of rectal cancer in 2014: Where are we going? World J Gastroenterol 2014; 20(32): 11249-11261 [PMID: 25170209 DOI: 10.3748/wjg.v20.i32.11249] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
191 Ye W, Shi L, Qian L, Sun Y, Sun X. Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis. Cancer Rep (Hoboken) 2019;2:e1188. [PMID: 32721108 DOI: 10.1002/cnr2.1188] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
192 Plodeck V, Rahbari NN, Weitz J, Radosa CG, Laniado M, Hoffmann RT, Zöphel K, Beuthien-Baumann B, Kotzerke J, van den Hoff J, Platzek I. FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences. Eur Radiol 2019;29:422-8. [PMID: 29980927 DOI: 10.1007/s00330-018-5589-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
193 Kihara K, Yamamoto S, Ohshiro T, Fujita S. Laparoscopic ovarian transposition prior to pelvic irradiation in a young female patient with advanced rectal cancer. Surg Case Rep 2015;1:113. [PMID: 26943437 DOI: 10.1186/s40792-015-0119-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
194 Sakuyama N, Kojima M, Kawano S, Matsuda Y, Mino-Kenudson M, Ochiai A, Ito M. Area of residual tumor is a robust prognostic marker for patients with rectal cancer undergoing preoperative therapy. Cancer Sci 2018;109:871-8. [PMID: 29388280 DOI: 10.1111/cas.13521] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
195 Neibart SS, Manne SL, Jabbour SK. Quality of Life After Radiotherapy for Rectal and Anal Cancer. Curr Colorectal Cancer Rep 2020;16:1-10. [PMID: 32632345 DOI: 10.1007/s11888-019-00448-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
196 Popek S, Tsikitis VL. Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior? World J Gastroenterol 2011; 17(7): 848-854 [PMID: 21412494 DOI: 10.3748/wjg.v17.i7.848] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
197 Chang JS, Yoon HI, Cha HJ, Chung Y, Cho Y, Keum KC, Koom WS. Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner. Radiat Oncol J 2013;31:41-7. [PMID: 23620868 DOI: 10.3857/roj.2013.31.1.41] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
198 Wong CS, Chu W, Ashamalla S, Fenech D, Berry S, Kiss A, Koritzinsky M. Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial. Clin Transl Radiat Oncol 2021;30:60-4. [PMID: 34401534 DOI: 10.1016/j.ctro.2021.07.001] [Reference Citation Analysis]
199 Kim JG, Song KD, Cha DI, Kim HC, Yu JI. Indistinguishable T2/T3-N0 rectal cancer on rectal magnetic resonance imaging: comparison of surgery-first and neoadjuvant chemoradiation therapy-first strategies. Int J Colorectal Dis 2018;33:1359-66. [PMID: 30003363 DOI: 10.1007/s00384-018-3131-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
200 Hill EJ, Roberts C, Franklin JM, Enescu M, West N, MacGregor TP, Chu KY, Boyle L, Blesing C, Wang LM, Mukherjee S, Anderson EM, Brown G, Dutton S, Love SB, Schnabel JA, Quirke P, Muschel R, McKenna WG, Partridge M, Sharma RA. Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer. Clin Cancer Res 2016;22:1922-31. [PMID: 26861457 DOI: 10.1158/1078-0432.CCR-15-1489] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
201 Kim J. Pelvic exenteration: surgical approaches. J Korean Soc Coloproctol 2012;28:286-93. [PMID: 23346506 DOI: 10.3393/jksc.2012.28.6.286] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
202 González JEB, Lavernia HC, Fraga JGP, Lemus SQ. Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer. Surg Endosc 2021. [PMID: 34231071 DOI: 10.1007/s00464-021-08583-y] [Reference Citation Analysis]
203 Thariat J, Hannoun-Levi JM, Sun Myint A, Vuong T, Gérard JP. Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol 2013;10:52-60. [PMID: 23183635 DOI: 10.1038/nrclinonc.2012.203] [Cited by in Crossref: 160] [Cited by in F6Publishing: 140] [Article Influence: 17.8] [Reference Citation Analysis]
204 Jankowski M, Bała D, Las-Jankowska M, Wysocki WM, Nowikiewicz T, Zegarski W. Overall treatment outcome - analysis of long-term results of rectal cancer treatment on the basis of a new parameter. Arch Med Sci 2020;16:825-33. [PMID: 32542084 DOI: 10.5114/aoms.2020.94330] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Dewdney A, Cunningham D, Chau I. Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies. Oncologist. 2013;18:833-842. [PMID: 23821325 DOI: 10.1634/theoncologist.2013-0022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
206 Xu ZS, Cheng H, Xiao Y, Cao JQ, Cheng F, Xu WJ, Ying JQ, Luo J, Xu W. Comparison of transanal endoscopic microsurgery with or without neoadjuvant therapy and standard total mesorectal excision in the treatment of clinical T2 low rectal cancer: a meta-analysis. Oncotarget 2017;8:115681-90. [PMID: 29383191 DOI: 10.18632/oncotarget.22091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
207 Li J, Shang W, Li Y, Fu S, Tian J, Lu L. Advanced nanomaterials targeting hypoxia to enhance radiotherapy. Int J Nanomedicine 2018;13:5925-36. [PMID: 30319257 DOI: 10.2147/IJN.S173914] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 7.7] [Reference Citation Analysis]
208 Nilsson PJ, Ahlberg M, Kordnejad S, Holm T, Martling A. Organ preservation following short-course radiotherapy for rectal cancer. BJS Open 2021;5:zrab093. [PMID: 34686879 DOI: 10.1093/bjsopen/zrab093] [Reference Citation Analysis]
209 Kulu Y, Hackert T, Debus J, Weber MA, Büchler MW, Ulrich A. [Role of neoadjuvant radiotherapy for rectal cancer : Is MRI-based selection a future model?]. Chirurg 2016;87:573-8. [PMID: 27339645 DOI: 10.1007/s00104-016-0236-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
210 Wu L, Pang S, Yao Q, Jian C, Lin P, Feng F, Li H, Li Y. Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age. Sci Rep 2017;7:3471. [PMID: 28615639 DOI: 10.1038/s41598-017-02992-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
211 Park Y, Kim K, Park HJ, Jeong SY, Park KJ, Han SW, Kim TY, Chie EK. Results of re-irradiation for pelvic recurrence in anorectal cancer patients. Br J Radiol 2019;92:20180794. [PMID: 30864822 DOI: 10.1259/bjr.20180794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
212 Qin Q, Wang L. Neoadjuvant therapy and subsequent treatment in rectal cancer: balance between oncological and functional outcomes. J Anus Rectum Colon 2018;2:47-58. [PMID: 31583321 DOI: 10.23922/jarc.2017-049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
213 Orsini RG, Wiggers T, DeRuiter MC, Quirke P, Beets-Tan RG, van de Velde CJ, Rutten HJ. The modern anatomical surgical approach to localised rectal cancer. EJC Suppl 2013;11:60-71. [PMID: 26217114 DOI: 10.1016/j.ejcsup.2013.07.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
214 Ciolina M, Caruso D, De Santis D, Zerunian M, Rengo M, Alfieri N, Musio D, De Felice F, Ciardi A, Tombolini V, Laghi A. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment. Radiol Med 2019;124:331-8. [PMID: 30560501 DOI: 10.1007/s11547-018-0978-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
215 Wu Y, Zheng H, Guo T, Keranmu A, Liu F, Xu Y. Temporary Diverting Stoma Improves Recovery of Anastomotic Leakage after Anterior Resection for Rectal Cancer. Sci Rep 2017;7:15930. [PMID: 29162894 DOI: 10.1038/s41598-017-16311-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
216 Zhang MX, Li XB, Guan BJ, Guan GX, Lin XY, Wu XD, Chi P, Xu BH. Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial. BMJ Open 2019;9:e025944. [PMID: 30904869 DOI: 10.1136/bmjopen-2018-025944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
217 Akgun E, Ozkok S, Tekin M, Yoldas T, Caliskan C, Kose T, Karabulut B, Sezak M, Elmas N, Ozutemiz O. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. World J Surg Oncol 2017;15:205. [PMID: 29166925 DOI: 10.1186/s12957-017-1275-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
218 Dreyer SB, Powell AG, McSorley ST, Waterston A, Going JJ, Edwards J, McMillan DC, Horgan PG. The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer. Ann Surg Oncol. 2017;24:1295-1303. [PMID: 27873100 DOI: 10.1245/s10434-016-5684-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
219 Peng Y, Wang L, Du C, Gu J. Expression of vascular endothelial growth factor can predict distant metastasis and disease-free survival for clinical stage III rectal cancer following 30-Gy/10-f preoperative radiotherapy. Int J Colorectal Dis. 2012;27:1555-1560. [PMID: 22645074 DOI: 10.1007/s00384-012-1485-8].] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
220 Gash KJ, Chambers AC, Cotton DE, Williams AC, Thomas MG. Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy. Br J Cancer 2017;117:210-9. [PMID: 28641310 DOI: 10.1038/bjc.2017.175] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
221 Venigalla S, Chowdhry AK, Wojcieszynski AP, Lukens JN, Plastaras JP, Metz JM, Ben-Josef E, Mahmoud NN, Reiss KA, Shabason JE. Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer. Clin Colorectal Cancer 2018;17:e557-68. [PMID: 29910004 DOI: 10.1016/j.clcc.2018.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
222 de'Angelis N, Landi F, Vitali GC, Memeo R, Martínez-Pérez A, Solis A, Assalino M, Vallribera F, Mercoli HA, Marescaux J, Mutter D, Ris F, Espin E, Brunetti F. Multicentre propensity score-matched analysis of laparoscopic versus open surgery for T4 rectal cancer. Surg Endosc 2017;31:3106-21. [PMID: 27826780 DOI: 10.1007/s00464-016-5332-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
223 Youssef FF, Parikh PJ, DeWees TA, Mutch MG, Tan BR Jr, Grigsby PW, Myerson RJ, Olsen JR. Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy. Adv Radiat Oncol 2016;1:94-100. [PMID: 28740875 DOI: 10.1016/j.adro.2016.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
224 Idasiak A, Galwas-Kliber K, Behrendt K, Wziętek I, Kryj M, Stobiecka E, Chmielik E, Suwiński R. Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study. Br J Radiol 2017;90:20160731. [PMID: 28466686 DOI: 10.1259/bjr.20160731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
225 Dehal A, Graff-Baker AN, Vuong B, Fischer T, Klempner SJ, Chang SC, Grunkemeier GL, Bilchik AJ, Goldfarb M. Neoadjuvant Chemotherapy Improves Survival in Patients with Clinical T4b Colon Cancer. J Gastrointest Surg. 2018;22:242-249. [PMID: 28933016 DOI: 10.1007/s11605-017-3566-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
226 Huang CM, Huang CW, Ma CJ, Yeh YS, Su WC, Chang TK, Tsai HL, Juo SH, Huang MY, Wang JY. Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy. J Oncol. 2020;2020:9437684. [PMID: 32411245 DOI: 10.1155/2020/9437684] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
227 Deijen CL, Tsai A, Koedam TW, Veltcamp Helbach M, Sietses C, Lacy AM, Bonjer HJ, Tuynman JB. Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol 2016;20:811-24. [PMID: 27853973 DOI: 10.1007/s10151-016-1545-0] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 15.6] [Reference Citation Analysis]
228 Wu JX, Wang Y, Chen N, Chen LC, Bai PG, Pan JJ. In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer. Radiat Oncol 2014;9:159. [PMID: 25052511 DOI: 10.1186/1748-717X-9-159] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
229 Snijders HS, van Leersum NJ, Henneman D, de Vries AC, Tollenaar RA, Stiggelbout AM, Wouters MW, Dekker JW. Optimal Treatment Strategy in Rectal Cancer Surgery: Should We Be Cowboys or Chickens? Ann Surg Oncol. 2015;22:3582-3589. [PMID: 25691277 DOI: 10.1245/s10434-015-4385-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
230 Cai W, Ge W, Hu H, Mao J. Rectal NETs and rectosigmoid junction NETs may need to be treated differently. Cancer Med 2020;9:971-9. [PMID: 31840409 DOI: 10.1002/cam4.2779] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
231 Kim Y, Kim DY, Kim TH, Kim SY, Baek JY, Kim MJ, Chang HJ, Cha Y, Park SC, Oh JH. Patterns of failure in rectal cancer with positive circumferential resection margin after surgery following preoperative chemoradiation: a propensity score matching analysis. Br J Radiol 2018;91:20180143. [PMID: 30129789 DOI: 10.1259/bjr.20180143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
232 Herman JM, Narang AK, Griffith KA, Zalupski MM, Reese JB, Gearhart SL, Azad NS, Chan J, Olsen L, Efron JE, Lawrence TS, Ben-Josef E. The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2013;85:e15-9. [PMID: 23058059 DOI: 10.1016/j.ijrobp.2012.09.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
233 Pechlivanides G, Gourtsoyianni S, Gouvas N, Sougklakos J, Xynos E. Management of the adenocarcinoma of the upper rectum: a reappraisal. Updates Surg 2021;73:513-26. [PMID: 33108641 DOI: 10.1007/s13304-020-00903-6] [Reference Citation Analysis]
234 Kripp M, Merx K, Wirtz RM, Gaiser T, Eidt S, Schwaab J, Post S, Wenz F, Hochhaus A, Hofheinz RD, Erben P. Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal Cancer. Gastroenterol Res Pract 2016;2016:3481578. [PMID: 27610130 DOI: 10.1155/2016/3481578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
235 Hong TS, Ryan DP, Borger DR, Blaszkowsky LS, Yeap BY, Ancukiewicz M, Deshpande V, Shinagare S, Wo JY, Boucher Y, Wadlow RC, Kwak EL, Allen JN, Clark JW, Zhu AX, Ferrone CR, Mamon HJ, Adams J, Winrich B, Grillo T, Jain RK, DeLaney TF, Fernandez-del Castillo C, Duda DG. A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys 2014;89:830-8. [PMID: 24867540 DOI: 10.1016/j.ijrobp.2014.03.034] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 9.7] [Reference Citation Analysis]
236 Liu Z, Meng X, Zhang H, Li Z, Liu J, Sun K, Meng Y, Dai W, Xie P, Ding Y, Wang M, Cai G, Tian J. Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer. Nat Commun. 2020;11:4308. [PMID: 32855399 DOI: 10.1038/s41467-020-18162-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
237 Hossain MS, Quadery Tonmoy MI, Islam MN, Islam MS, Afif IK, Singha Roy A, Fariha A, Al Reza H, Bahadur NM, Rahaman MM. MicroRNAs expression analysis shows key affirmation of Synaptopodin-2 as a novel prognostic and therapeutic biomarker for colorectal and cervical cancers. Heliyon 2021;7:e07347. [PMID: 34195444 DOI: 10.1016/j.heliyon.2021.e07347] [Reference Citation Analysis]
238 Bosch SL, Nagtegaal ID. The Importance of the Pathologist's Role in Assessment of the Quality of the Mesorectum. Curr Colorectal Cancer Rep 2012;8:90-8. [PMID: 22611342 DOI: 10.1007/s11888-012-0124-7] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
239 Lee JB, Kim HS, Ham A, Chang JS, Shin SJ, Beom SH, Koom WS, Kim T, Han YD, Han DH, Hur H, Min BS, Lee KY, Kim NK, Park YR, Lim JS, Ahn JB. Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis. Front Oncol 2020;10:609313. [PMID: 33537238 DOI: 10.3389/fonc.2020.609313] [Reference Citation Analysis]
240 Fucini C, Pucciani F, Elbetti C, Gattai R, Russo A. Preoperative radiochemotherapy in t3 operable low rectal cancers: a gold standard? World J Surg. 2010;34:1609-1614. [PMID: 20213202 DOI: 10.1007/s00268-010-0513-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
241 Knight WRC, Yip C, Wulaningsih W, Jacques A, Griffin N, Zylstra J, Van Hemelrijck M, Maisey N, Gaya A, Baker CR, Kelly M, Gossage JA, Lagergren J, Landau D, Goh V, Davies AR, Ngan S, Qureshi A, Deere H, Green M, Chang F, Mahadeva U, Gill-Barman B, George S, Dunn J, Zeki S, Meenan J, Hynes O, Tham G, Iezzi C; Guy's and St Thomas' Oesophago‐Gastric Research Group. Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus. BJS Open 2019;3:767-76. [PMID: 31832583 DOI: 10.1002/bjs5.50211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
242 Armstrong G, Croft J, Corrigan N, Brown JM, Goh V, Quirke P, Hulme C, Tolan D, Kirby A, Cahill R, O'Connell PR, Miskovic D, Coleman M, Jayne D. IntAct: intra-operative fluorescence angiography to prevent anastomotic leak in rectal cancer surgery: a randomized controlled trial. Colorectal Dis. 2018;20:O226-O234. [PMID: 29751360 DOI: 10.1111/codi.14257] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
243 Rutkowski A, Pietrzak L, Kryński J, Zając L, Bednarczyk M, Olesiński T, Szpakowski M, Saramak P, Pierzankowski I, Hevelke P, Surowski P, Bujko K. The gentamicin-collagen implant and the risk of distant metastases of rectal cancer following short-course radiotherapy and curative resection: the long-term outcomes of a randomized study. Int J Colorectal Dis 2018;33:1087-96. [PMID: 29656304 DOI: 10.1007/s00384-018-3045-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
244 Schiffmann L, Klautke G, Wedermann N, Gock M, Prall F, Fietkau R, Rau B, Klar E. Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis. BMC Cancer. 2013;13:388. [PMID: 23947828 DOI: 10.1186/1471-2407-13-388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
245 Peng JY, Li ZN, Wang Y. Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers. World J Gastroenterol 2013; 19(32): 5227-5237 [PMID: 23983425 DOI: 10.3748/wjg.v19.i32.5227] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
246 Yin JD, Song LR, Lu HC, Zheng X. Prediction of different stages of rectal cancer: Texture analysis based on diffusion-weighted images and apparent diffusion coefficient maps. World J Gastroenterol 2020; 26(17): 2082-2096 [PMID: 32536776 DOI: 10.3748/wjg.v26.i17.2082] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
247 Kye BH, Cho HM. Overview of radiation therapy for treating rectal cancer. Ann Coloproctol 2014;30:165-74. [PMID: 25210685 DOI: 10.3393/ac.2014.30.4.165] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
248 Peng YF, Yu WD, Pan HD, Wang L, Li M, Yao YF, Zhao J, Gu J. Tumor regression grades: Potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy. World J Gastroenterol 2015; 21(6): 1851-1856 [PMID: 25684951 DOI: 10.3748/wjg.v21.i6.1851] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
249 Swellengrebel HA, Peters EG, Cats A, Visser O, Blaauwgeers HG, Verwaal VJ, van Velthuysen ML, Cense HA, Bruin SC, Marijnen CA. Multidisciplinary discussion and management of rectal cancer: a population-based study. World J Surg 2011;35:2125-33. [PMID: 21720869 DOI: 10.1007/s00268-011-1181-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
250 Skóra T, Nowak-Sadzikowska J, Martynów D, Wszołek M, Sas-Korczyńska B. Preoperative short-course radiotherapy in rectal cancer patients: results and prognostic factors. J Radiat Oncol 2018;7:77-84. [PMID: 29576860 DOI: 10.1007/s13566-017-0340-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
251 Ni X, Yang J, Li M. Imaging-guided curative surgical resection of pancreatic cancer in a xenograft mouse model. Cancer Lett. 2012;324:179-185. [PMID: 22617626 DOI: 10.1016/j.canlet.2012.05.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
252 Fan WH, Xiao J, An X, Jiang W, Li LR, Gao YH, Chen G, Kong LH, Lin JZ, Wang JP, Pan ZZ, Ding PR. Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer. J Cancer Res Clin Oncol 2017;143:1461-7. [PMID: 28386648 DOI: 10.1007/s00432-017-2383-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
253 Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O'Callaghan C, Myint AS, Bessell E, Thompson LC. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821-828. [PMID: 19269520 DOI: 10.1016/S0140-6736(09) 60485-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
254 Park IJ, Yu CS, Lim SB, Yoon YS, Kim CW, Kim TW, Kim JH, Kim JC. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy. World J Gastroenterol 2015; 21(11): 3274-3281 [PMID: 25805934 DOI: 10.3748/wjg.v21.i11.3274] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
255 Sturiale A, Martellucci J, Zurli L, Vaccaro C, Brusciano L, Limongelli P, Docimo L, Valeri A. Long-term functional follow-up after anterior rectal resection for cancer. Int J Colorectal Dis. 2017;32:83-88. [PMID: 27695976 DOI: 10.1007/s00384-016-2659-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 7.2] [Reference Citation Analysis]
256 Emile SH, de Lacy FB, Keller DS, Martin-Perez B, Alrawi S, Lacy AM, Chand M. Evolution of transanal total mesorectal excision for rectal cancer: From top to bottom. World J Gastrointest Surg 2018; 10(3): 28-39 [PMID: 29588809 DOI: 10.4240/wjgs.v10.i3.28] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
257 Guan X, Wei R, Yang R, Lu Z, Liu E, Zhao Z, Chen H, Yang M, Liu Z, Jiang Z, Wang X. Risk and Prognosis of Secondary Bladder Cancer After Radiation Therapy for Rectal Cancer: A Large Population-Based Cohort Study. Front Oncol 2020;10:586401. [PMID: 33569344 DOI: 10.3389/fonc.2020.586401] [Reference Citation Analysis]
258 Nilsson PJ, van Etten B, Hospers GA, Påhlman L, van de Velde CJ, Beets-Tan RG, Blomqvist L, Beukema JC, Kapiteijn E, Marijnen CA, Nagtegaal ID, Wiggers T, Glimelius B. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial. BMC Cancer 2013;13:279. [PMID: 23742033 DOI: 10.1186/1471-2407-13-279] [Cited by in Crossref: 198] [Cited by in F6Publishing: 160] [Article Influence: 24.8] [Reference Citation Analysis]
259 Tseng M, Soon YY, Vellayappan B, Ho F, Tey J. Radiation therapy for rectal cancer. J Gastrointest Oncol 2019;10:1238-50. [PMID: 31949945 DOI: 10.21037/jgo.2018.12.04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
260 Lim YK, Law WL, Liu R, Poon JT, Fan JF, Lo OS. Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers. World J Surg Oncol. 2010;8:23. [PMID: 20346160 DOI: 10.1186/1477-7819-8-23] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
261 Chen YH, Wang CW, Wei MF, Tzeng YS, Lan KH, Cheng AL, Kuo SH. Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal Cancer. Cancers (Basel) 2019;11:E1204. [PMID: 31430901 DOI: 10.3390/cancers11081204] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
262 Brouwer NPM, Bos ACRK, Lemmens VEPP, Tanis PJ, Hugen N, Nagtegaal ID, de Wilt JHW, Verhoeven RHA. An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients. Int J Cancer. 2018;143:2758-2766. [PMID: 30095162 DOI: 10.1002/ijc.31785] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 26.7] [Reference Citation Analysis]
263 Sadrizadeh A, Bagheri R, Soltani E, Anvari K, Toussi MS, Moadikhah S. The Comparison of the Advantages of Neoadjuvant Chemoradiotherapy versus Postoperative Chemoradiotherapy: Outcomes in Esophageal Cancer Patients. J Gastrointest Cancer 2018;49:50-6. [PMID: 28025816 DOI: 10.1007/s12029-016-9899-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
264 Damin DC, Lazzaron AR. Evolving treatment strategies for colorectal cancer: A critical review of current therapeutic options. World J Gastroenterol 2014; 20(4): 877-887 [PMID: 24574762 DOI: 10.3748/wjg.v20.i4.877] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
265 Abraha I, Aristei C, Palumbo I, Lupattelli M, Trastulli S, Cirocchi R, De Florio R, Valentini V. Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma. Cochrane Database Syst Rev. 2018;10:CD002102. [PMID: 30284239 DOI: 10.1002/14651858.cd002102.pub3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
266 Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol. 2012;13:1152-1160. [PMID: 23017669 DOI: 10.1016/s1470-2045(12)70348-0] [Cited by in Crossref: 224] [Cited by in F6Publishing: 104] [Article Influence: 24.9] [Reference Citation Analysis]
267 Liapi A, Mavrantonis C, Lazaridis P, Kourkouni E, Zevlas A, Zografos G, Theodoropoulos G. Validation and comparative assessment of low anterior resection syndrome questionnaires in Greek rectal cancer patients. Ann Gastroenterol 2019;32:185-92. [PMID: 30837792 DOI: 10.20524/aog.2019.0350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
268 Muirhead R, Drinkwater K, O'Cathail SM, Adams R, Glynne-Jones R, Harrison M, Hawkins MA, Sebag-Montefiore D, Gilbert DC. Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015. Clin Oncol (R Coll Radiol) 2017;29:188-97. [PMID: 27810119 DOI: 10.1016/j.clon.2016.10.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
269 Kulu Y, Büchler MW, Ulrich A. [Radiotherapy-associated morbidity and mortality in rectal surgery]. Chirurg 2013;84:951-6. [PMID: 24170116 DOI: 10.1007/s00104-013-2515-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
270 Otero de Pablos J, Mayol J. Controversies in the Management of Lateral Pelvic Lymph Nodes in Patients With Advanced Rectal Cancer: East or West? Front Surg 2019;6:79. [PMID: 32010707 DOI: 10.3389/fsurg.2019.00079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
271 Hanna MH, Vinci A, Pigazzi A. Diverting ileostomy in colorectal surgery: when is it necessary? Langenbecks Arch Surg. 2015;400:145-152. [PMID: 25633276 DOI: 10.1007/s00423-015-1275-1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 11.0] [Reference Citation Analysis]
272 Yeo SG, Kim DY. An update on preoperative radiotherapy for locally advanced rectal cancer. J Korean Soc Coloproctol 2012;28:179-87. [PMID: 22993703 DOI: 10.3393/jksc.2012.28.4.179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
273 Drebber U, Madeja M, Odenthal M, Wedemeyer I, Mönig SP, Brabender J, Bollschweiler E, Hölscher AH, Schneider PM, Dienes HP, Vallböhmer D. β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis. Int J Colorectal Dis 2011;26:1127-34. [DOI: 10.1007/s00384-011-1213-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
274 Tang MJ, Ding SB, Hu WY. Fibrinogen and Albumin Score Changes during Preoperative Treatment Can Predict Prognosis in Patients with Locally Advanced Rectal Cancer. Gastroenterol Res Pract 2019;2019:3514586. [PMID: 31814824 DOI: 10.1155/2019/3514586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
275 Fung-Kee-Fung SD. Therapeutic approaches in the management of locally advanced rectal cancer. J Gastrointest Oncol 2014;5:353-61. [PMID: 25276408 DOI: 10.3978/j.issn.2078-6891.2014.067] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
276 Kim MJ, Kim ES, Yeo SG. Definitive high-dose radiotherapy with concurrent chemotherapy for locally advanced rectal cancer: A case report and literature review. Medicine (Baltimore) 2016;95:e5059. [PMID: 27749573 DOI: 10.1097/MD.0000000000005059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
277 Bown EJ, Lloyd GM, Boyle KM, Miller AS. Rectal cancer: prognostic indicators of long-term outcome in patients considered for surgery. Int J Colorectal Dis. 2014;29:147-155. [PMID: 24051904 DOI: 10.1007/s00384-013-1772-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
278 McNair AG, Macefield RC, Blencowe NS, Brookes ST, Blazeby JM. 'Trial Exegesis': Methods for Synthesizing Clinical and Patient Reported Outcome (PRO) Data in Trials to Inform Clinical Practice. A Systematic Review. PLoS One 2016;11:e0160998. [PMID: 27571514 DOI: 10.1371/journal.pone.0160998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
279 Cui J, Fang H, Zhang L, Wu YL, Zhang HZ. Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy. Chronic Dis Transl Med 2016;2:10-6. [PMID: 29063019 DOI: 10.1016/j.cdtm.2016.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
280 Wen Z, Chen Y, Yang X, Lu B, Liu Y, Shen B, Yu S. Application of magnetic resonance diffusion kurtosis imaging for distinguishing histopathologic subtypes and grades of rectal carcinoma. Cancer Imaging 2019;19:8. [PMID: 30744694 DOI: 10.1186/s40644-019-0192-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
281 Shin YS, Yoon YS, Lim SB, Yu CS, Kim TW, Chang HM, Park JH, Ahn SD, Lee SW, Choi EK, Kim JC, Kim JH. Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer. Radiat Oncol J 2016;34:177-85. [PMID: 27730804 DOI: 10.3857/roj.2016.01872] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
282 Huang CM, Huang MY, Huang CW, Tsai HL, Su WC, Chang WC, Wang JY, Shi HY. Machine learning for predicting pathological complete response in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy. Sci Rep. 2020;10:12555. [PMID: 32724164 DOI: 10.1038/s41598-020-69345-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
283 Bosch SL, Verhoeven RHA, Lemmens VEPP, Simmer F, Poortmans P, de Wilt JHW, Nagtegaal ID. Type of preoperative therapy and stage-specific survival after surgery for rectal cancer: a nationwide population-based cohort study. Virchows Arch 2019;475:745-55. [PMID: 31463728 DOI: 10.1007/s00428-019-02638-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
284 Yu WD, Peng YF, Pan HD, Wang L, Li K, Gu J. Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma. World J Gastroenterol 2014; 20(43): 16258-16267 [PMID: 25473181 DOI: 10.3748/wjg.v20.i43.16258] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
285 Xu J, Qin X, Wang J, Zhang S, Zhong Y, Ren L, Wei Y, Zeng S, Wan D, Zheng S; Society of Surgery; Chinese Medical Association; Committee of Colorectal Cancer, Chinese Anti-cancer Association. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol. 2011;137:1379-1396. [PMID: 21796415 DOI: 10.1007/s00432-011-0999-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
286 Georgiou PA, Mohammed Ali S, Brown G, Rasheed S, Tekkis PP. Extended lymphadenectomy for locally advanced and recurrent rectal cancer.Int J Colorectal Dis. 2017;32:333-340. [PMID: 28130592 DOI: 10.1007/s00384-016-2711-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
287 Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW. Second primary malignancy risk after radiotherapy in rectal cancer survivors. World J Gastroenterol 2018; 24(40): 4586-4595 [PMID: 30386108 DOI: 10.3748/wjg.v24.i40.4586] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
288 Tayyab M, Zaidi H, Vieira P, Qureshi T, Figueiredo N, Parvaiz A. A tailored approach to abdominoperineal resection for rectal cancer: multicentre analysis of short-term outcomes and impact on oncological survival. Langenbecks Arch Surg 2021;406:813-9. [PMID: 33638682 DOI: 10.1007/s00423-021-02122-y] [Reference Citation Analysis]
289 Trakarnsanga A, Ithimakin S, Weiser MR. Treatment of locally advanced rectal cancer: Controversies and questions. World J Gastroenterol 2012; 18(39): 5521-5532 [PMID: 23112544 DOI: 10.3748/wjg.v18.i39.5521] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
290 Feng S, Yan P, Zhang Q, Li Z, Li C, Geng Y, Wang L, Zhao X, Yang Z, Cai H, Wang X. Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery for patients with locally advanced rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 2020;35:1355-69. [PMID: 32488419 DOI: 10.1007/s00384-020-03621-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
291 Chen C, Sun P, Rong J, Weng HW, Dai QS, Ye S. Short Course Radiation in the Treatment of Localized Rectal Cancer: A Systematic Review and Meta-Analysis. Sci Rep 2015;5:10953. [PMID: 26055266 DOI: 10.1038/srep10953] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
292 Yeom SS, Park IJ, Yang DH, Lee JL, Yoon YS, Kim CW, Lim SB, Park SH, Kim HJ, Yu CS, Kim JC. Variation in the Height of Rectal Cancers According to the Diagnostic Modalities. Ann Coloproctol 2019;35:24-9. [PMID: 30879281 DOI: 10.3393/ac.2018.07.31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
293 Avallone A, Piccirillo MC, Delrio P, Pecori B, Di Gennaro E, Aloj L, Tatangelo F, D'Angelo V, Granata C, Cavalcanti E, Maurea N, Maiolino P, Bianco F, Montano M, Silvestro L, Terranova Barberio M, Roca MS, Di Maio M, Marone P, Botti G, Petrillo A, Daniele G, Lastoria S, Iaffaioli VR, Romano G, Caracò C, Muto P, Gallo C, Perrone F, Budillon A. Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial). BMC Cancer 2014;14:875. [PMID: 25421252 DOI: 10.1186/1471-2407-14-875] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
294 Glynne-Jones R, Kronfli M. Locally advanced rectal cancer: a comparison of management strategies. Drugs. 2011;71:1153-1177. [PMID: 21711061 DOI: 10.2165/11591330-000000000-00000] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
295 Wolf M, Zehentmayr F, Belka C. [Radiotherapy of rectal cancer]. Radiologe 2012;52:545-9. [PMID: 22618627 DOI: 10.1007/s00117-011-2286-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
296 Langrand-Escure J, Diao P, Garcia MA, Wang G, Guy JB, Espenel S, Guillaume E, Rehailia-Blanchard A, Pigné G, de Laroche G, Kaczmarek D, Muron T, Porcheron J, Phelip JM, Vallard A, Magné N. Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey. Sci Rep 2018;8:10708. [PMID: 30013090 DOI: 10.1038/s41598-018-29040-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
297 Francescutti V, Coates A, Thabane L, Goldsmith CH, Levine MN, Simunovic M. Patterns of use and outcomes for radiation therapy in the Quality Initiative in Rectal Cancer (QIRC) trial. Can J Surg 2013;56:E148-53. [PMID: 24284154 DOI: 10.1503/cjs.019012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
298 Kang SB, Cho JR, Jeong SY, Oh JH, Ahn S, Choi S, Kim DW, Lee BH, Youk EG, Park SC, Heo SC, Lee DS, Ryoo SB, Park JW, Park HC, Lee SM, Kang SI, Kim MH, Oh HK, Shin R, Kim MJ, Lee KH, Kim YH, Kim JS, Lee KW, Lee HS, Kim HJ, Park YS, Sohn DK, Park KJ; Seoul Colorectal Research Group (SECOG). Quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE): A long-term prospective, multicentre, cohort study. Lancet Reg Health West Pac 2021;6:100087. [PMID: 34327411 DOI: 10.1016/j.lanwpc.2020.100087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Hanna CR, Slevin F, Appelt A, Beavon M, Adams R, Arthur C, Beasley M, Duffton A, Gilbert A, Gollins S, Harrison M, Hawkins MA, Laws K, O'Cathail S, Porcu P, Robinson M, Sebag-Montefiore D, Teo M, Teoh S, Muirhead R. Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020. Clin Oncol (R Coll Radiol) 2021;33:214-23. [PMID: 33423883 DOI: 10.1016/j.clon.2020.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
300 Wang L, Gu J. Risk factors for symptomatic anastomotic leakage after low anterior resection for rectal cancer with 30 Gy/10 f/2 w preoperative radiotherapy. World J Surg. 2010;34:1080-1085. [PMID: 20145926 DOI: 10.1007/s00268-010-0449-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
301 Yakar M, Etiz D. Artificial intelligence in rectal cancer. Artif Intell Gastroenterol 2021; 2(2): 10-26 [DOI: 10.35712/aig.v2.i2.10] [Reference Citation Analysis]
302 Sterzing F, Hoehle F, Ulrich A, Jensen A, Debus J, Muenter M. Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients. J Radiat Res 2015;56:169-76. [PMID: 25341424 DOI: 10.1093/jrr/rru089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
303 Pfeiffer P, Gruenberger T, Glynne-Jones R. Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first? Ther Adv Med Oncol 2018;10:1758835918787993. [PMID: 30093921 DOI: 10.1177/1758835918787993] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
304 Pettersson D, Lörinc E, Holm T, Iversen H, Cedermark B, Glimelius B, Martling A. Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer. Br J Surg. 2015;102:972-978; discussion 978. [PMID: 26095256 DOI: 10.1002/bjs.9811] [Cited by in Crossref: 120] [Cited by in F6Publishing: 97] [Article Influence: 20.0] [Reference Citation Analysis]
305 Ao T, Kajiwara Y, Yamada K, Shinto E, Mochizuki S, Okamoto K, Yamadera M, Yonemura K, Ueno H. Cancer-induced spiculation on computed tomography: a significant preoperative prognostic factor for colorectal cancer. Surg Today 2019;49:629-36. [PMID: 30790053 DOI: 10.1007/s00595-019-01780-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
306 Sinukumar S, Mehta S, Ostwal V, Jatal S, Saklani A. Impact of type of surgery (laparoscopic versus open) on the time to initiation of adjuvant chemotherapy in operable rectal cancers. Indian J Gastroenterol 2015;34:310-3. [PMID: 26245505 DOI: 10.1007/s12664-015-0579-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
307 Patel SA, Chen YH, Hornick JL, Catalano P, Nowak JA, Zukerberg LR, Bleday R, Shellito PC, Hong TS, Mamon HJ. Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection. Dis Colon Rectum 2014;57:449-59. [PMID: 24608301 DOI: 10.1097/DCR.0b013e3182a70709] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
308 Wheelwright S, Permyakova NV, Calman L, Din A, Fenlon D, Richardson A, Sodergren S, Smith PWF, Winter J, Foster C; Members of the Study Advisory Committee. Does quality of life return to pre-treatment levels five years after curative intent surgery for colorectal cancer? Evidence from the ColoREctal Wellbeing (CREW) study. PLoS One 2020;15:e0231332. [PMID: 32271835 DOI: 10.1371/journal.pone.0231332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
309 Lee JH, Chie EK, Kim K, Jeong SY, Park KJ, Park JG, Kang GH, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW. The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer. BMC Cancer 2013;13:576. [PMID: 24304825 DOI: 10.1186/1471-2407-13-576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
310 Schrag D. Evolving role of neoadjuvant therapy in rectal cancer. Curr Treat Options Oncol 2013;14:350-64. [PMID: 23828092 DOI: 10.1007/s11864-013-0242-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
311 Stelzner S, Koehler C, Stelzer J, Sims A, Witzigmann H. Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview. Int J Colorectal Dis. 2011;26:1227-1240. [PMID: 21603901 DOI: 10.1007/s00384-011-1235-3] [Cited by in Crossref: 99] [Cited by in F6Publishing: 78] [Article Influence: 9.9] [Reference Citation Analysis]
312 Miyamoto R, Kikuchi K, Uchida A, Ozawa M, Sano N, Tadano S, Inagawa S, Oda T, Ohkohchi N. Pathological complete response after preoperative chemotherapy including FOLFOX plus bevacizumab for locally advanced rectal cancer: A case report and literature review. Int J Surg Case Rep 2019;62:85-8. [PMID: 31476559 DOI: 10.1016/j.ijscr.2019.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
313 Qin C, Ren X, Xu K, Chen Z, He Y, Song X. Does Preoperative Radio(chemo)therapy Increase Anastomotic Leakage in Rectal Cancer Surgery? A Meta-Analysis of Randomized Controlled Trials. Gastroenterol Res Pract 2014;2014:910956. [PMID: 25477955 DOI: 10.1155/2014/910956] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
314 Gollins S, West N, Sebag-Montefiore D, Susnerwala S, Falk S, Brown N, Saunders M, Quirke P, Ray R, Parsons P, Griffiths G, Maughan T, Adams R, Hurt C. A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. Br J Cancer. 2018;119:697-706. [PMID: 30116024 DOI: 10.1038/s41416-018-0209-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
315 Haddock MG. Intraoperative radiation therapy for colon and rectal cancers: a clinical review. Radiat Oncol. 2017;12:11. [PMID: 28077144 DOI: 10.1186/s13014-016-0752-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
316 Nguyen TH, Tran HX, Thai TT, La DM, Tran HD, Le KT, Pham VTN, Le ANT, Nguyen BH. Feasibility and Safety of Laparoscopic Radical Colectomy for T4b Colon Cancer at a University Hospital in Vietnam. Biomed Res Int 2020;2020:1762151. [PMID: 33224972 DOI: 10.1155/2020/1762151] [Reference Citation Analysis]
317 Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ, Watanabe T. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065. [PMID: 27189416 DOI: 10.1038/nrdp.2015.65] [Cited by in Crossref: 485] [Cited by in F6Publishing: 485] [Article Influence: 80.8] [Reference Citation Analysis]